BLSM
BlossomHill Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$25.74
−4.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -5.19x
- Price / sales
- —
- Price / cash flow
- -16.81x
Enterprise value
- Enterprise value
- $695.8M
- EV / sales
- —
- EV / EBITDA
- -10.94x
- EV / EBIT
- -10.87x
- Market cap
- $788.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026